03-05-2023 : 769 Pharmacists work as Medical Representative, of which 39 work as Senior Medical Representative * 02-06-2020 : 216 non Pharmacists work as Medical Representative, and 54 work as Senior Medical Representative * 05-06-2023 : In Lebanon, 88 generic medicinal products are more expensive than their Originators * 31-12-2019 : A medicinal product refused in Europe is marketed in Lebanon * 05-06-2023 : At least 332 medicinal products are available on the Lebanese market and are not available in the country of origin * 05-06-2023 : The price of the most expensive medicine available in Lebanon is 30434557 LL * 05-06-2023 : At least 1309 medicinal products are more expensive in Lebanon than in the countries of origin * 01-01-2019 : Daktavira, a generic of Daklinza, is registered in Lebanon but has no public price * 31-12-2019 : 352 medicinal products have been declared as non-marketed or withdrawn * 09-11-2021 : 64.72% of lebanese pharmacists are female * 31-12-2019 : 486 medicines were submitted to the Ministry of Health for a marketing authorization, and 514 medicines were registered to date * 15-06-2018 : The Minister of Public Health, has decided to suspend the commercialization of AB Slim (Ab Care Medical Herbs), which contains sibutramine, sildenafil and phenolphthalein * 01-06-2020 : Some Non-Marketed medicines are still imported * 01-06-2020 : Ixempra, a medicinal product withdrawn in Europe is imported to lebanon * 01-06-2020 : A vaccine made in India, removed from WHO list of prequalified vaccines, is submitted for registration in Lebanon * 01-06-2020 : Lebanon has 14 CROs, and is ranked as one of the largest countries in the world in clinical studies. According to the WHO, 817 clinical studies are currently conducted in Lebanon. * 05-01-2021 : * 01-10-2023 : Adakveo is now withdrawn from use in the European Union due to lack of therapeutic efficacy *
Exforge 5/160mg° : | |
Type | Medicine Withdrawn |
Originator | B |
Agent | Khalil Fattal & Fils |
Distributor | Khalil Fattal & Fils |
Laboratory | Novartis |
Manufacturer | Novartis Farmaceutica SA |
Origin | Spain |
ATC | C09DB01 |
Revision Date | 01/01/2012 |
Exforge 5/160mg° :
Exforge 5/160mg° :
Exforge 5/160mg° :
Exforge 5/160mg° :
Exforge 5/160mg° :
Hazard Level |
---|
◼ Major |
◼ Moderate |
◼ Minor |
◼ Safe |
Exforge 5/160mg° :
Exforge 5/160mg° :
Frequency | Percentage |
---|---|
Very Common | ≥ 1/10 |
Common | ≥ 1/100 - < 1/10 |
Uncommon | ≥ 1/1,000 - < 1/100 |
Rare | ≥ 1/10,000 - < 1/1,000 |
Very Rare | < 1/10,000 |
Unknown | Cannot be Estimated |
Effect | Frequency |
---|---|
Abdominal discomfort | Common |
Abdominal pain | Common |
Abdominal pain upper | Common |
Alopecia | Uncommon |
Angioedema (Angioneurotic oedema) (Quincke oedema) | Very rare |
Anxiety | Uncommon |
Arrhythmia | Very rare |
Arthralgia (Pain joint) (Joint ache) | Uncommon |
Asthenia | Common |
Atrial fibrillation | Very rare |
Back pain | Uncommon |
Blood bilirubin increased | Very rare |
Blood creatinine increased | Not known |
Blood potassium increased | Not known |
Bradycardia | Very rare |
Change of bowel habit | Uncommon |
Chest pain | Uncommon |
Cholestasis | Very rare |
Confusional state | Rare |
Constipation | Uncommon |
Coordination abnormal | Uncommon |
Cough | Uncommon |
Decreased appetite | Uncommon |
Depression | Uncommon |
Dermatitis bullous | Not known |
Dermatitis exfoliative | Very rare |
Diarrhoea (Diarrhea) | Uncommon |
Diplopia | Uncommon |
Discomfort | Uncommon |
Dizziness | Common |
Dry mouth (Xerostomia) | Uncommon |
Dysguesia (taste perversion) (Taste abnormality) (Taste disturbance) | Uncommon |
Dyspepsia | Uncommon |
Dyspnoea (dyspnea) | Uncommon |
Erectile dysfunction | Uncommon |
Erythema | Uncommon |
Erythema multiforme | Very rare |
Extrapyramidal disorder | Not known |
Face oedema | Common |
Fatigue | Common |
Flushing | Common |
Gastritis | Very rare |
Gingival hyperplasia | Very rare |
Gynecomastia (Gynaecomastia) | Uncommon |
Haematocrit decreased | Not known |
Haemoglobin decreased | Not known |
Headache | Common |
Hepatic enzyme increased | Very rare |
Hepatitis | Very rare |
Hot flush | Common |
Hypercalcaemia | Uncommon |
Hyperglycaemia | Very rare |
Hyperhidrosis | Uncommon |
Hyperlipidaemia | Uncommon |
Hypersensitivity | Rare |
Hypertonia | Very rare |
Hyperuricaemia | Uncommon |
Hypoesthesia | Uncommon |
Hypokalaemia | Common |
Hyponatraemia (Hyponatremia) | Uncommon |
Hypotension | Uncommon |
Influenza | Common |
Insomnia | Uncommon |
Jaundice | Very rare |
Joint swelling | Common |
Laryngeal pain | Uncommon |
Leucopenia (Leukopenia) | Very rare |
Liver function test abnormal | Very rare |
Malaise | Uncommon |
Micturition disorder | Uncommon |
Mood altered | Uncommon |
Mood swings | Uncommon |
Muscle spasms | Uncommon |
Myalgia | Uncommon |
Myocardial infarction | Very rare |
Nasopharyngitis | Common |
Nausea | Common |
Neuropathy peripheral | Very rare |
Neutropenia | Not known |
Nocturia | Uncommon |
Non-cardiac chest pain | Uncommon |
Oedema | Common |
Oedema peripheral | Common |
Orthostatic dizziness | Uncommon |
Orthostatic hypotension | Uncommon |
Pain | Uncommon |
Palpitations | Common |
Pancreatitis | Very rare |
Paraesthesia (paresthesia) | Uncommon |
Photosensitivity reaction | Uncommon |
Pollakiuria (Urinary frequency) | Uncommon |
Polyuria | Rare |
Pruritus | Uncommon |
Purpura | Uncommon |
Renal failure | Not known |
Renal impairment | Not known |
Rhinitis | Uncommon |
Serum sickness | Not known |
Skin discolouration (Dyschromia) | Uncommon |
Skin rash | Uncommon |
Sleep disorder (Sleep disturbance) | Uncommon |
Somnolence | Common |
Stevens-Johnson syndrome | Very rare |
Syncope | Uncommon |
Tachycardia | Uncommon |
Thrombocytopenia (Thrombopenia) | Very rare |
Thrombocytopenic purpura | Very rare |
Tinnitus | Uncommon |
Tremor | Uncommon |
Urticaria | Very rare |
Vasculitis | Very rare |
Ventricular tachycardia | Very rare |
Vertigo | Uncommon |
Visual disturbance | Uncommon |
Vomiting | Uncommon |
Weight decreased (Weight loss) | Uncommon |
Weight increased (weight gain) | Uncommon |
NB : Products With Same Indication |
Different Units By MoH Code
Exforge 5/160mg° MoH 5051 :
Form | Tablet, Film-Coated |
Packaging | Blisters |
Package Size | Box of 28 |
Strength | 5/160mg |
Storage Condition | <25°C Away from moisture |
Stratum | N/A |
NSSF | ✘ |
Quarantine | ✘ |
Reg. Number | 24876/07 |
Submission date | 01/01/2007 |
Registration Year | 2007 |
Withdrawn Date | 2018 |
Price Comparison
You have to register to view this info
Drop File